Global Herpes Labialis (Oral Herpes) Pipeline Report 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Herpes Labialis (Oral Herpes), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with the latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Herpes Labialis (Oral Herpes) and special features on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter-strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Herpes Labialis (Oral Herpes) Overview
  3. Therapeutics Development
  4. Pipeline Products for Herpes Labialis (Oral Herpes) - Overview
  5. Pipeline Products for Herpes Labialis (Oral Herpes) - Comparative Analysis
  6. Herpes Labialis (Oral Herpes) - Therapeutics under Development by Companies
  7. Herpes Labialis (Oral Herpes) - Therapeutics under Investigation by Universities/Institutes
  8. Herpes Labialis (Oral Herpes) Products Glance
  9. Late-Stage Products
  10. Clinical-Stage Products
  11. Early-Stage Products
  12. Herpes Labialis (Oral Herpes) - Products under Development by Companies
  13. Herpes Labialis (Oral Herpes) - Products under Investigation by Universities/Institutes
  14. Herpes Labialis (Oral Herpes) - Companies Involved in Therapeutics Development
  • Beech Tree Labs, Inc.
  • Foamix Pharmaceuticals Ltd.
  • Mymetics Corporation
  • NanoViricides, Inc.
  • Onxeo SA
  • Shulov Innovative Science Ltd.
  • TGV-Laboratories
  • Vironova AB

For more information visit http://www.researchandmarkets.com/research/wm2mm9/herpes_labialis.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs, Sexual and Reproductive Health Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs, Sexual and Reproductive Health Drugs